Natus Medical Management Performance

Natus Medical Incorporated -- USA Stock  

USD 32.50  0.85  2.55%

Analysis of Natus Medical manpower and management performance can provide insight into Natus Medical stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Natus Medical Incorp future performance. Check also Trending Equities.

Natus Medical Management Effectiveness

The company has return on total asset (ROA) of 0.89 % which means that it generated profit of $0.89 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (4.83) % meaning that it created substantial loss on money invested by shareholders.

Natus Medical Profit Margins

The company has Profit Margin (PM) of (4.05) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 1.92 % which suggests for every 100 dollars of sales it generated a net operating income of 0.02.

Natus Medical Insider Trading

Natus Medical Incorp Benchmark Summation

The output start index for this execution was zero with a total number of output elements of seventeen. Natus Medical Incorp Price Series Summation is a cross summation of Natus Medical price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.

Natus Medical Stakeholders

James Hawkins CEO and President and Director
Robert Gunst Independent Chairman of the Board
William Moore Co-Founder, Director, Chairman of Compensation Committee and Member of Audit Committee
Ajay Bhave Vice President - Global Engineering
Jonathan Kennedy CFO, Senior Vice President
Christopher Chung Vice President - Medical Affairs, Quality & Regulatory, Ph.D
Austin Noll Vice President and General Manager - Neurology Strategic Business Unit
Leslie McDonnell Vice President and General Manager - Newborn Care Business Unit, MBA
Doris Engibous Independent Director
Will Moore Independent Director
Barbara Paul Director
Kenneth Ludlum Independent Director, MBA
Kenneth Traverso VP and General Manager of Newborn Care SBU


Natus Medical Working Change Over Time

Working Capital

Tenure Analysis

Natus Medical Employment Tenure
Natus Medical employes about 1726 people. The company is managed by 13 executives with total tenure of roughly 141 years, averanging almost 10.0 years of service per executive having 132.0 employee per reported executive.


Natus Medical Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.33April 19, 2017
Natus Medical Incorporated normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Manpower Efficiency

Return on Natus Medical Manpower
Revenue Per Employee 414.4 K
Revenue Per Executive 38.5 M
Net Income Per Employee 41.8 K
Net Loss Per Executive 1.6 M
Working Capital Per Employee 95.2 K
Working Capital Per Executive 12.6 M

Per Employee

Natus Medical Per Employee Growth Over Time

Net Income Per Employee

Revenue Per Employee

Number of Employees

Natus Medical Number of Employees Analysis
Natus Medical Incorporated is number one stock in number of employees category among related companies. The total workforce of Medical Equipment industry is currently estimated at about 15,540. Natus Medical retains roughly 1,726 in number of employees claiming about 11% of all equities under Medical Equipment industry.

Earnings Per Share

Natus Medical Incorp Earnings Per Share
According to company disclosure Natus Medical Incorporated has Earnings Per Share of -0.62 times. This is 182.67% lower than that of the Healthcare sector, and significantly lower than that of Medical Equipment industry, The Earnings Per Share for all stocks is 126.96% higher than the company.
Earnings per Share is one of the most important measures of the current share price of a firm, and is used by investors to determine the company overall profitability; especially when it is compared to the EPS of similar companies.